Abstract
Management of cerebral edema and elevated intracranial pressure (ICP) is a critical determinant of patient outcomes. Osmotherapy is the most important options in the medical treatments including controlled ventilation, osmotherapy, maintenance of brain and body homeostasis and sedation. Mannitol and hypertonic saline (HTS) are frequently used among osmotic agents related to brain edema and high ICP. Although mannitol is recommended in guidelines, hypertonic saline seems advantageous over mannitol in many situations, such as providing sustained hemodynamic stability and immunologic effects and less rebound phenomenon. Thus, HTS is emerging as a secure alternative to mannitol in the treatment of intracranial hypertension.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
